HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Female Genital Neoplasms

Subscribe to New Research on Female Genital Neoplasms

Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).

Also Known As:

Genital Neoplasms, Female; Neoplasms, Female Genital; Neoplasms, Gynecologic; Female Genital Neoplasm; Genital Neoplasm, Female; Gynecologic Neoplasm; Neoplasm, Female Genital; Neoplasm, Gynecologic; Gynecologic Neoplasms

Networked: 81 relevant articles (2 outcomes, 4 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1.	Neoplasms (Cancer)
2.	Carcinoma (Carcinomatosis)
3.	Endometrial Neoplasms (Endometrial Cancer)
4.	Neoplasm Metastasis (Metastasis)
5.	Leiomyoma (Uterine Fibroids)

Experts

1.	Bollmann, Reinhardt: 1 article (11/2015)
2.	Hildenbrand, Ralf: 1 article (11/2015)
3.	Horn, Olympia: 1 article (11/2015)
4.	Kurbacher, Ann Tabea: 1 article (11/2015)
5.	Herz, Susanne: 1 article (11/2015)
6.	Kurbacher, Jutta Anna: 1 article (11/2015)
7.	Kurbacher, Christian Martin: 1 article (11/2015)
8.	Mrozińska, Sandra: 1 article (01/2013)
9.	Kiałka, Marta: 1 article (01/2013)
10.	Ociepka, Agnieszka: 1 article (01/2013)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Female Genital Neoplasms:

1.	Raloxifene (Evista)FDA Link 11/01/1996 - "These data indicate that SERMs such as raloxifene and tamoxifen act as estrogen antagonists in uterine myometrial cells and suggest that this class of compounds may be effective for treatment of this important gynecologic neoplasm."
2.	Selective Estrogen Receptor Modulators (SERM)IBA 11/01/1996 - "These data indicate that SERMs such as raloxifene and tamoxifen act as estrogen antagonists in uterine myometrial cells and suggest that this class of compounds may be effective for treatment of this important gynecologic neoplasm."
3.	Tamoxifen FDA LinkGeneric 11/01/1996 - "These data indicate that SERMs such as raloxifene and tamoxifen act as estrogen antagonists in uterine myometrial cells and suggest that this class of compounds may be effective for treatment of this important gynecologic neoplasm."
4.	Estrogen AntagonistsIBA 11/01/1996 - "These data indicate that SERMs such as raloxifene and tamoxifen act as estrogen antagonists in uterine myometrial cells and suggest that this class of compounds may be effective for treatment of this important gynecologic neoplasm."
5.	RadiumIBA 10/28/1971 - "[Studies with computers of the dosage distribution in the pelvis under intracavital radium treatment of gynecologic neoplasms]." 10/01/1973 - "[Colposcopy and colpocytology after radium treatment of gynecologic neoplasms]." 07/01/1964 - "[THE EFFECT OF COMBINED RADIUM-TELECOBALT IRRADIATION OF GYNECOLOGIC NEOPLASMS ON THE BLOOD COAGULATION SYSTEM]."
6.	Estrogens (Estrogen)FDA Link 01/15/1980 - "The demonstration of estrogen receptor in malignant carcinoid tumor expands the spectrum of non-breast or non-gynecologic neoplasms that contain the receptor. " 12/04/1975 - "When estrogen use was adjusted for concomitant variables such as obesity, hypertension, diabetes, parity, referral pattern, age at diagnosis, year of diagnosis and other gynecologic neoplasms, the magnitude of the increased relative risk was associated with several of these variables, and was highest in patients without obesity and hypertension. " 12/04/1975 - "To determine the association between the incidence of endometrial cancer and the use of estrogen in menopausal and post-menopausal women, we retrospectively compared 317 patients with adenocarcinoma of the endometrium with an equal number of matched controls having other gynecologic neoplasms; 152 patients used estrogen, as compared to 54 of 317 controls. " 04/01/1987 - "A study of cytoplasmic and nuclear estrogen and progestin receptors in gynecologic neoplasms."
7.	Progesterone Receptors (Progesterone Receptor)IBA 04/01/1987 - "A study of cytoplasmic and nuclear estrogen and progestin receptors in gynecologic neoplasms."
8.	Hydroxyurea (Hydrea)FDA LinkGeneric 08/01/1964 - "PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: UROLOGIC AND GYNECOLOGIC NEOPLASMS."
9.	Biological Tumor Markers (Tumor Markers)IBA 09/01/1991 - "[Tumor markers in the early diagnosis of recurrence in gynecologic neoplasms: combined determination of CA-125, CA 15-3, CA 72.4, SCC, 90 K]." 03/01/1990 - "Tumor markers in gynecologic neoplasms." 07/01/1988 - "[The place of tumor markers in breast and gynecologic neoplasms]." 03/01/1990 - "The applications of tumor markers and steroid receptors in gynecologic neoplasms are described. " 07/20/1979 - "[T antigen and CEA; comparison between 2 tumor markers in breast cancer and malignant gynecologic neoplasms]."
10.	DNA (Deoxyribonucleic Acid)IBA 05/01/1991 - "[Clinical significance of the determination of cellular DNA content in gynecologic neoplasms]." 05/01/1981 - "The significance of nuclear DNA findings related to gynecologic neoplasms is discussed." 06/15/1969 - "Alterations in chromosomes and DNA content in gynecologic neoplasms." 01/01/1996 - "To establish a basis for the interpretation of DNA flow cytometric results of gynecologic neoplasms, paraffin blocks from 121 patients with a diagnosis of serous cystadenoma (n = 37), mucinous cystadenoma (n = 28), leiomyoma (n = 41), and fibrothecoma (n = 15), and normal tissue samples obtained from some of these patients, including ovary (n = 20), cervix (n = 20), and myometrium (n = 20) were analyzed for nuclear DNA content. "

Therapies and Procedures

1.	Drug Therapy (Chemotherapy) 07/01/1986 - "[Criteria for the determination of the immediate efficacy of chemotherapy in gynecologic neoplasms]." 03/17/1962 - "[Experimental studies on selective chemotherapy of gynecologic neoplasms]." 07/25/1970 - "[Chemotherapy of malignant gynecologic neoplasms]." 08/31/1965 - "[Onco-chemotherapy by introduction into retzius space in treatment of female genital neoplasms]." 11/01/1992 - "[Intra-arterial infusion chemotherapy of female genital neoplasms]."
2.	Radiotherapy 01/01/1983 - "[Urinary enzyme excretion in cytostatic and radiotherapy of gynecologic neoplasms]." 01/01/1973 - "[Current dosimetry within the scope of radiotherapy for gynecologic neoplasms]." 05/16/1968 - "[Treatment of intestinal disorders caused by radiations in patients during ionizing radiotherapy of gynecologic neoplasms]." 07/01/2005 - "Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms." 01/01/1993 - "Radiotherapy versus radical surgery for gynecologic neoplasms: carcinomas of the cervix and vulva."
3.	Brachytherapy 10/01/1997 - "Intracavitary brachytherapy in the treatment of gynecologic neoplasms." 03/01/1991 - "[High dose brachytherapy in gynecologic neoplasms. "
4.	Aftercare (After-Treatment) 03/08/1979 - "[Clinical and urological after care in gynecologic neoplasms]." 06/10/1977 - "[Organization and realization of after-care examinations in cancer patients, especially with gynecologic neoplasms]."
5.	Dye Lasers 01/01/1985 - "Five patients with various gynecologic neoplasms were treated with photodynamic therapy using 630-nm light delivered from an argon dye laser system following the intravenous injection of hematoporphyrin derivative (HpD). "